Use of Dexamethasone in Uterine Artery Embolization
The primary purpose of this study is to investigate the effects of dexamethasone on inflammatory reactions after uterine artery embolization. The secondary purpose of this study it to investigate the effects of dexamethasone on postembolization syndrome (severe pain, nasea and vomiting).
Uterine Myoma|Adenomyosis
DRUG: Dexamethasone|DRUG: Normal saline
Inflammatory reactions, CRP, WBC, neutrophil (%), cortisol : pre-UAE, post-UAE 12 h, post-UAE-24 h IL-6 : pre-UAE, post-UAE-24 h, 24 hours
Pain, Immediately after UAE, post-UAE 1, 2, 4, 6, 8, 12, 24 h, 24 hours|Nausea and vomiting, Immediately after UAE, post-UAE 1, 2, 4, 6, 8, 12, 24 h, 24 hours|Sucessful rate at 3 month after UAE, Utrerine volume and complete necrosis incidence, 3 month
The primary purpose of this study is to investigate the effects of dexamethasone on inflammatory reactions after uterine artery embolization. The secondary purpose of this study it to investigate the effects of dexamethasone on postembolization syndrome (severe pain, nasea and vomiting).